188.44  4.91 (2.68%)		06-09 16:00
Open: 185.01 High: 189.21 Volume: 3,221,210		Pre. Close: 183.53 Low: 183.75 Market Cap: 133,372(M)

Short term
Mid term
Targets	6-month :	220.99	1-year :	258.12
Resists	First :	189.21	Second :	220.99
Pivot price	177.97
Supports	First :	171.73	Second :	160.92
MAs	MA(5) :	184.19	MA(20) :	174.61
	MA(100) :	195.21	MA(250) :	203.61
MACD	MACD :	1.9	Signal :	-0.3
%K %D	K(14,3) :	87.3	D(3) :	86.1
RSI	RSI(14): 62.9
52-week	High :	242.28	Low :	160.92

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ DHR ] has closed below upper band by 7.4%. Bollinger Bands are 12.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	189.3 - 190.24	190.24 - 191.18
Low:	181.57 - 182.53	182.53 - 183.51
Close:	186.88 - 188.42	188.42 - 189.98

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Tue, 09 Jun 2026
Wolfe Research Downgrades Danaher Corporation (DHR) - Insider Monkey

Tue, 09 Jun 2026
Wolfe Research Downgrades Danaher Corporation (DHR) - Yahoo Finance

Mon, 08 Jun 2026
Danaher (DHR) Moves Towards Acquisition of Masimo (MASI) - GuruFocus

Mon, 08 Jun 2026
Danaher Corporation (DHR) Stock Analysis: Unveiling a 32.54% Potential Upside for Investors - DirectorsTalk Interviews

Sun, 07 Jun 2026
Why Wall Street Sees Danaher (DHR) Benefiting From Improving Industry Conditions - Yahoo Finance

Fri, 05 Jun 2026
Reassessing Danaher (DHR) Valuation After Mixed Share Performance And Conflicting Undervaluation Signals - simplywall.st

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Shares Out	708 (M)
Shares Float	631 (M)
Held by Insiders	10.7 (%)
Held by Institutions	84.5 (%)
Shares Short	8,400 (K)
Shares Short P.Month	8,180 (K)

EPS	5.15
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	74.81
Profit Margin	14.8 %
Operating Margin	22.9 %
Return on Assets (ttm)	4.1 %
Return on Equity (ttm)	7 %
Qtrly Rev. Growth	3.7 %
Gross Profit (p.s.)	20.65
Sales Per Share	35.01
EBITDA (p.s.)	11.21
Qtrly Earnings Growth	9.8 %
Operating Cash Flow	6,440 (M)
Levered Free Cash Flow	4,570 (M)

PE Ratio	36.59
PEG Ratio	1.1
Price to Book value	2.51
Price to Sales	5.38
Price to Cash Flow	20.7

Dividend	0.4
Forward Dividend	0
Dividend Yield	0.2%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.